A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer

Article Article scientifique Lettre A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer eng 2022-05-11 2022 author Terrier Jean Division of General Internal Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Geneva Platelet Group, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; Clinical Pharmacology and Toxicology Division, Anesthesiology, Pharmacology, Intensive Care and Emergency Medicine Department, Geneva University Hospitals, 1205 Geneva, Switzerland. Electronic address: jean.terrier@hcuge.ch. 536564 Département d'anesthésiologie, pharmacologie et soins intensifs (APSIC) author Relecom Alan Medical Oncology Division, Oncology Department, Geneva University Hospitals, 1205 Geneva, Switzerland. author Borgeaud Simon Division of Clinical Neurosciences, Neurology Department, Geneva University Hospitals, 1205 Geneva, Switzerland. 656416 author Bridel Claire 0000-0001-7267-7676 Division of Clinical Neurosciences, Neurology Department, Geneva University Hospitals, 1205 Geneva, Switzerland. 507621 author Seebach Jorg Dieter Division of Immunology and Allergology, Geneva University Hospitals, 1205 Geneva, Switzerland. 647894 Département de médecine (DEMED) author Assal Frédéric Division of Clinical Neurosciences, Neurology Department, Geneva University Hospitals, 1205 Geneva, Switzerland. 527005 Département des neurosciences cliniques (OTONO) author Reny Jean-Luc 0000-0002-7528-7363 Division of General Internal Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Geneva Platelet Group, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland. 704339 Département de médecine (DEMED) author Serratrice Jacques Division of General Internal Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland. 836481 Département de médecine (DEMED) 754-756 10.1016/j.therap.2022.05.002 35660110 0040-5957 https://www.sciencedirect.com/science/article/pii/S0040595722000944 Anticancer Clinical pharmacology Immunology Humans Small Cell Lung Carcinoma / drug therapy Immune Checkpoint Inhibitors / therapeutic use Cerebral Ventriculitis / drug therapy Lung Neoplasms / drug therapy Lung Neoplasms / pathology Dewey 616.8 Dewey 616 Dewey 617 56 Département de médecine 221 63 Département d'anesthésiologie, pharmacologie, soins intensifs et urgences 229 61 Département des neurosciences cliniques 226 false 11 Plaquettes et antithrombotiques 13 319 Groupe Perrier Arnaud (Médecine interne générale, de réhabilitation et de gériatrie) 585 Thérapie 77 6 fb373518-a49d-43b3-b2ed-72aa6a04d75a Article (Published version) Restricted manuscript.pdf 263318 application/pdf e14c6855871988693ba0f6115c8d4b2cf20dfd378e305cab71a1c834fa8d8380 restrictedAccess Faculté de médecine / Section de médecine clinique / Département de médecine Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques

Title	Published in	Access level	OA Policy	Year	Views	Downloads

A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer	Thérapie			2022	59	0

Archive ouverte UNIGE

Borgeaud, Simon